# Trade Mark Journal No.2026/030 24 July 2026

## UK00004394792 29 May 2026 (5,42)

International priority date claimed: 13 February 2026 (United States of America) (99652428)

Class 5
  Biological, medicinal and pharmaceutical preparations, namely, oligonucleotide based therapeutics for the treatment of cardiovascular, cardiomyopathies, and heart muscle related diseases and disorders.
Class 42
  Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology.

Atrium Therapeutics, Inc.

Representative: Abion UK Limited